CF
KRRO icon

Corebridge Financial’s Korro Bio KRRO Stock Holding History

Corebridge Financial’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,019
Closed -$52.6K – 1467
2025
Q1 		$52.6K Sell
3,019
-14
-0.5% -$415 ﹤0.01% 2718
2024
Q4 		$115K Sell
3,033
-228
-7% -$11.7K ﹤0.01% 2483
2024
Q3 		$109K Sell
3,261
-20
-0.6% -$842 ﹤0.01% 2579
2024
Q2 		$111K Buy
+3,281
New +$181K ﹤0.01% 2534

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

Corebridge Financial's KRRO Position: Q2 2025 in Review

Corebridge Financial sold out of Korro Bio (KRRO) in Q2 2025, closing a stake of 3,019 shares — an estimated $52.6K sold.

Corebridge Financial first reported a position in KRRO in Q2 2024 and held it in 4 quarters. The position peaked at $115K in Q4 2024. 70 funds tracked by Wall St. Rank hold KRRO as of Q2 2025.

  • Corebridge Financial reported no remaining Korro Bio position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 3,019 Korro Bio shares in Q2 2025, an estimated $52.6K.
  • Corebridge Financial first reported a position in Korro Bio in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Korro Bio position peaked at $115K in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Korro Bio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.